ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

8 Centers Awarded Comprehensive Designation

February 15, 1991

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014